betaine has been researched along with Liver Dysfunction in 25 studies
glycine betaine : The amino acid betaine derived from glycine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaine was shown to be a potential agent for the treatment of hepatopathy associated with SBS, which was evidenced by NMR, although the markers for hepatic lesion have not presented significant decrease." | 6.79 | Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome. ( Domenici, F; Elias, J; Teixeira Araújo, G; Vannucchi, H, 2014) |
| "For the prevention of liver dysfunction in women, a choline adequate intake of 425 mg/day was established." | 5.14 | Choline status is not a reliable indicator of moderate changes in dietary choline consumption in premenopausal women. ( Abratte, CM; Axume, J; Caudill, MA; Li, R; Moriarty, DJ; Wang, W, 2009) |
| " The focus should be on the long-term use of betaine in large patient populations with liver diseases characterized by development of fatty liver, especially non-alcoholic fatty liver disease and alcoholic liver disease." | 4.93 | Betaine chemistry, roles, and potential use in liver disease. ( Day, CR; Kempson, SA, 2016) |
| "Betaine was shown to be a potential agent for the treatment of hepatopathy associated with SBS, which was evidenced by NMR, although the markers for hepatic lesion have not presented significant decrease." | 2.79 | Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome. ( Domenici, F; Elias, J; Teixeira Araújo, G; Vannucchi, H, 2014) |
| "Betaine is a kind of water-soluble quaternary amine-type alkaloid widely existing in food, such as wheat germ, beet, spinach, shrimp and wolfberry." | 2.72 | Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. ( Dai, S; Gong, L; Li, Y; Ma, C; Wang, C, 2021) |
| "Betaine has been shown to protect internal organs, improve vascular risk factors, and enhance performance." | 2.42 | Betaine in human nutrition. ( Craig, SA, 2004) |
| "Taurine or betaine pretreatment in lipopolysaccharide-injected rats caused significant decreases in plasma transaminase activities and hepatic malondialdehyde and DC levels, and significant increases in glutathione and alpha-tocopherol (not betaine) levels without changing ascorbic acid levels and SOD and glutathione peroxidase activities in the liver." | 1.33 | The effect of taurine or betaine pretreatment on hepatotoxicity and prooxidant status induced by lipopolysaccharide treatment in the liver of rats. ( Aykaç-Toker, G; Balkan, J; Doğru-Abbasoğlu, S; Parldar, FH; Uysal, M, 2005) |
| "Betaine uptake was required for this protective effect, which was already observed at betaine concentrations of 1 mmol/L." | 1.31 | Prevention of bile acid-induced apoptosis by betaine in rat liver. ( Fischer, R; Graf, D; Häussinger, D; Kircheis, G; Kurz, AK; Reinehr, R, 2002) |
| "Carbon tetrachloride-injected rats were given liquid diets with and without betaine for 7 d." | 1.30 | Betaine reduces hepatic lipidosis induced by carbon tetrachloride in Sprague-Dawley rats. ( Barak, AJ; Beckenhauer, HC; Junnila, M; Rahko, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (44.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosas-Rodríguez, JA | 1 |
| Valenzuela-Soto, EM | 1 |
| Wang, C | 1 |
| Ma, C | 1 |
| Gong, L | 1 |
| Dai, S | 1 |
| Li, Y | 1 |
| Pourmehdi, A | 1 |
| Sakhaei, Z | 1 |
| Alirezaei, M | 1 |
| Dezfoulian, O | 1 |
| Teixeira Araújo, G | 1 |
| Domenici, F | 1 |
| Elias, J | 1 |
| Vannucchi, H | 1 |
| Murray, TV | 1 |
| Dong, X | 1 |
| Sawyer, GJ | 1 |
| Caldwell, A | 1 |
| Halket, J | 1 |
| Sherwood, R | 1 |
| Quaglia, A | 1 |
| Dew, T | 1 |
| Anilkumar, N | 1 |
| Burr, S | 1 |
| Mistry, RK | 1 |
| Martin, D | 1 |
| Schröder, K | 1 |
| Brandes, RP | 1 |
| Hughes, RD | 1 |
| Shah, AM | 1 |
| Brewer, AC | 1 |
| Šišková, K | 1 |
| Dubničková, M | 1 |
| Pašková, Ľ | 1 |
| Rajdl, D | 1 |
| Ďuračková, Z | 1 |
| Muchová, J | 1 |
| Pauliková, I | 1 |
| Racek, J | 1 |
| Day, CR | 1 |
| Kempson, SA | 1 |
| Graf, D | 1 |
| Kurz, AK | 1 |
| Reinehr, R | 1 |
| Fischer, R | 1 |
| Kircheis, G | 1 |
| Häussinger, D | 1 |
| BALL, CR | 1 |
| Craig, SA | 1 |
| Balkan, J | 1 |
| Parldar, FH | 1 |
| Doğru-Abbasoğlu, S | 1 |
| Aykaç-Toker, G | 1 |
| Uysal, M | 1 |
| Abratte, CM | 1 |
| Wang, W | 1 |
| Li, R | 1 |
| Axume, J | 1 |
| Moriarty, DJ | 1 |
| Caudill, MA | 1 |
| Lever, M | 1 |
| Sizeland, PC | 1 |
| Bason, LM | 1 |
| Hayman, CM | 1 |
| Robson, RA | 1 |
| Chambers, ST | 1 |
| Murakami, T | 1 |
| Nagamura, Y | 1 |
| Hirano, K | 1 |
| Junnila, M | 1 |
| Barak, AJ | 1 |
| Beckenhauer, HC | 1 |
| Rahko, T | 1 |
| Semmler, F | 1 |
| Kandziora, J | 1 |
| Abbou, R | 1 |
| Mahoudeau, D | 1 |
| Dubrisay, J | 1 |
| Volteau, M | 1 |
| Babucke, G | 1 |
| Sarre, B | 1 |
| Palmari, V | 1 |
| Pietranera, P | 1 |
| Cairella, M | 1 |
| Volpari, B | 1 |
| Nicrosini, F | 1 |
| Gäbler, H | 1 |
| Cachin, M | 1 |
| Pergola, F | 1 |
4 reviews available for betaine and Liver Dysfunction
| Article | Year |
|---|---|
The glycine betaine role in neurodegenerative, cardiovascular, hepatic, and renal diseases: Insights into disease and dysfunction networks.
Topics: Betaine; Cardiovascular Diseases; Cell Size; Humans; Hyperhomocysteinemia; Kidney Diseases; Liver Di | 2021 |
Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms.
Topics: Animals; Betaine; Chemical and Drug Induced Liver Injury; Humans; Liver Diseases; Liver Diseases, Al | 2021 |
Betaine chemistry, roles, and potential use in liver disease.
Topics: Animals; Betaine; Humans; Kidney; Liver; Liver Diseases; Liver Diseases, Alcoholic; Non-alcoholic Fa | 2016 |
Betaine in human nutrition.
Topics: Animals; Betaine; Cardiovascular Diseases; DNA Methylation; Gastrointestinal Agents; Humans; Hyperho | 2004 |
5 trials available for betaine and Liver Dysfunction
| Article | Year |
|---|---|
Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome.
Topics: Adult; Aged; Betaine; Fatty Liver; Female; Gastrointestinal Agents; Humans; Liver Diseases; Male; Mi | 2014 |
Choline status is not a reliable indicator of moderate changes in dietary choline consumption in premenopausal women.
Topics: Adolescent; Adult; Betaine; Choline; Diet; Female; Folic Acid; Genotype; Humans; Liver Diseases; Nut | 2009 |
Abnormal glycine betaine content of the blood and urine of diabetic and renal patients.
Topics: Adult; Albuminuria; Betaine; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus; Fe | 1994 |
[Treatment of liver diseases, especially of fatty liver with betaine citrate].
Topics: Adult; Betaine; Clinical Trials as Topic; Drug Evaluation; Fatty Liver; Humans; Liver Diseases | 1977 |
[New therapeutic aspects in substitutive treatment with homologous and heterologous enzymes of gastro-entero-biliary hyposthenic diseases].
Topics: Adolescent; Adult; Aged; Amylases; Betaine; Biliary Tract Diseases; Clinical Trials as Topic; Duoden | 1970 |
16 other studies available for betaine and Liver Dysfunction
| Article | Year |
|---|---|
Betaine effects against asthma-induced oxidative stress in the liver and kidney of mice.
Topics: Animals; Antioxidants; Asthma; Betaine; Disease Models, Animal; Female; Glucocorticoids; Inflammatio | 2020 |
NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in mice.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Betaine; Blotting, Western; Cells, Cultured; Cyste | 2015 |
Betaine increases the butyrylcholinesterase activity in rat plasma.
Topics: Animals; Betaine; Butyrylcholinesterase; Diet, High-Fat; Enzyme Activation; Liver Diseases; Male; Ra | 2016 |
Prevention of bile acid-induced apoptosis by betaine in rat liver.
Topics: Animals; Apoptosis; Betaine; Bile Acids and Salts; Cell Membrane; Cells, Cultured; Cholestasis; fas | 2002 |
ACTIONS OF BETAINE, CARNITINE AND CHOLINE ON THE PATTERN OF HEPATIC LIPOSIS IN MICE FED A HIGH-FAT, LOW-PROTEIN DIET.
Topics: Animals; Betaine; Carnitine; Choline; Diet, High-Fat; Diet, Protein-Restricted; Dietary Fats; Dietar | 1964 |
The effect of taurine or betaine pretreatment on hepatotoxicity and prooxidant status induced by lipopolysaccharide treatment in the liver of rats.
Topics: Animals; Antioxidants; Betaine; Chemical and Drug Induced Liver Injury; Lipopolysaccharides; Liver D | 2005 |
The recovering effect of betaine on carbon tetrachloride-induced liver injury.
Topics: Alanine Transaminase; Animals; Betaine; Carbon Tetrachloride; Cell Nucleus; Chemical and Drug Induce | 1998 |
Betaine reduces hepatic lipidosis induced by carbon tetrachloride in Sprague-Dawley rats.
Topics: Administration, Oral; Animals; Betaine; Body Weight; Carbon Tetrachloride; Chemical and Drug Induced | 1998 |
[Therapeutic experience with the lipotropic hepatic drug Flacar in the internal medicine practice].
Topics: Adult; Aged; Betaine; Drug Combinations; Drug Evaluation; Female; Humans; Internal Medicine; Liver D | 1976 |
[Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
Topics: Adult; Aged; Arginine; Betaine; Humans; Liver Diseases; Middle Aged; Quaternary Ammonium Compounds; | 1965 |
[Clinical experience with betain citrate (author's transl)].
Topics: Adult; Aged; Betaine; Citrates; Fatty Liver; Female; Humans; Hyperbilirubinemia; Leucyl Aminopeptida | 1973 |
[Betaine aspartate in the therapy of liver diseases].
Topics: Adult; Aged; Aspartic Acid; Betaine; Female; Humans; Lipid Metabolism; Liver Diseases; Liver Functio | 1972 |
[Therapeutic activity of betaine aspartate].
Topics: Adult; Aspartic Acid; Betaine; Dyspepsia; Evaluation Studies as Topic; Humans; Liver Diseases; Middl | 1972 |
[Stea 16].
Topics: Adolescent; Adult; Aged; Betaine; Butyrates; Cholagogues and Choleretics; Cholestasis; Cyclohexanes; | 1972 |
[A new biochemical aspect of liver therapy].
Topics: Betaine; Fatty Liver; Humans; Liver Diseases | 1971 |
[Betaine aspartate in the hepato-digestive domain].
Topics: Aspartic Acid; Betaine; Dyspepsia; Fatty Liver; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; | 1966 |